Cobicistat: a Novel Pharmacoenhancer for Co-Formulation with HIV Protease and Integrase Inhibitors

Human immunodeficiency virus (HIV) therapy has evolved over the last 20 years from mono-drug therapy given five times daily to regimens consisting of three or four drugs combined in a single-tablet dosed once daily. To allow once-daily administration, several drugs require pharmacokinetic boosting b...

Descripción completa

Detalles Bibliográficos
Autores principales: Nathan, Bavithra, Bayley, Jake, Waters, Laura, Post, Frank A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108106/
https://www.ncbi.nlm.nih.gov/pubmed/25134475
http://dx.doi.org/10.1007/s40121-013-0013-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108106/
https://www.ncbi.nlm.nih.gov/pubmed/25134475
http://dx.doi.org/10.1007/s40121-013-0013-7

Ejemplares similares